In our previous study we showed that a low IRX2 gene expression in early stage primary breast tumors is associated with the presence of DTCs in the bone marrow and was also associated with shortened survival of breast cancer patients in one analyzed breast cancer data set [16], indicating a possible function of the IRX2 protein as a metastasis suppressing protein. Here, IRX2 is linked to breast cancer.